OTC Drugs, Medical Devices and Diagnostics: Global Markets

Report Highlights

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

Report Includes

• 36 data tables and 69 additional tables
• An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics
• Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region
• Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management
• A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)
• A discussion on ESG challenges and practices in the industry
• Review of patents issued for OTC drugs, medical devices, and diagnostics
• Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
• Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
• Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG

Report Scope

The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.